Article | April 1, 2021

Accelerating cGMP Production Using Rapid Tech Transfer

Source: Cytiva

Engaging a contract development and manufacturing organization (CDMO) and outsourcing certain activities can accelerate process development and manufacturing by taking advantage of added expertise and capacity. However, the decision to outsource must be carefully made, evaluating the benefits and risks.

Teva Pharmaceuticals worked with Cytiva’s Fast Trak™ team for the transfer and scale-up of one of their biologics manufacturing processes.

Teva began with a strong manufacturing process on a single-use platform. Their goal was to establish consistent performance at scale-up compared to an existing lower scale process. Achieving this required process knowledge and experience with the cell type and expression system.

This article presents the partnership and a successful tech transfer based on effective communication, conscientious project management, and widespread technical and regulatory expertise.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online